首页> 外文期刊>Internal medicine. >Contrast-induced nephropathy after percutaneous coronary intervention in simple lesions: Risk factors and incidence are affected by the definition utilized
【24h】

Contrast-induced nephropathy after percutaneous coronary intervention in simple lesions: Risk factors and incidence are affected by the definition utilized

机译:经皮冠状动脉介入治疗简单病变后的造影剂肾病:危险因素和发生率受所用定义的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Aim To compare the incidence, and risk factors, in-hospital and at the 18-month prognosis of contrastinduced nephropathy (CIN) according to the definition utilized: as an increase in serum creatinine (Scr) ≥0.5 mg/dL (CIN 1) or as an increase in Scr ≥25% above baseline values (CIN 2). Methods and Results We prospectively evaluated CIN according to two different definitions in 150 patients who underwent percutaneous coronary intervention (PCI) in simple lesions employing a low-medium dose of contrast media. Incidence of CIN was higher using the CIN 2 definition than CIN 1 (9.3% vs. 4%; p=0.0133). Patients with CIN 1 had a higher incidence of chronic kidney disease (CKD) (66.7% vs. 13.9%; p=0.006), higher mean serum creatinine levels (1.35±0.42 vs. 0.98±0.35; p=0.001) and lower mean eGFR levels (58.3±19.6 vs. 84±25.9; p=0.002). Patients with CIN 2 had a higher incidence of anemia (57.1% vs. 30.9%; p=0.049) and a higher mean contrast media volume was used (142.6±62.2 mL vs. 110.6±57.2 mL; p=0.05). In the multivariate analysis the only significant variable associated with CIN (CIN 2) was a higher volume of contrast media (OR=1.01; p=0.04). There were no differences in the major in-hospital events, but patients with CIN (both definitions) had a longer in-hospital stay. A persistent rise in serum creatinine at discharge occurred in only one patient. There were no differences between patients with and without CIN in events at the follow-up, with the exception of an increased risk of new hospitalization in patients with CIN 2. Conclusion After PCI employing low-medium dose of contrast media the incidence of CIN varied according to the definition used. Neither of the two definitions offers additional information compared with the other. Chronic kidney disease and baseline parameters of renal function are the risk factors associated with CIN 1; anemia and higher volume of contrast media are associated with CIN 2.
机译:目的根据使用的定义比较造影剂肾病(CIN)在医院和18个月预后中的发生率和危险因素:血清肌酐(Scr)≥0.5 mg / dL(CIN 1)升高或Scr高于基线值(CIN 2)≥25%的增加。方法和结果我们对150名接受中低剂量造影剂的简单病变经皮冠状动脉介入治疗(PCI)的患者根据两种不同的定义进行了前瞻性评估。使用CIN 2定义时,CIN的发生率高于CIN 1(9.3%对4%; p = 0.0133)。 CIN 1患者的慢性肾脏疾病(CKD)发生率较高(66.7%vs. 13.9%; p = 0.006),平均血清肌酐水平较高(1.35±0.42 vs. 0.98±0.35; p = 0.001)和较低的平均值eGFR水平(58.3±19.6 vs. 84±25.9; p = 0.002)。 CIN 2患者的贫血发生率更高(57.1%比30.9%; p = 0.049),平均造影剂体积也更高(142.6±62.2 mL vs. 110.6±57.2 mL; p = 0.05)。在多变量分析中,与CIN(CIN 2)相关的唯一显着变量是较高体积的造影剂(OR = 1.01; p = 0.04)。在主要的住院事件中没有差异,但是CIN(两个定义)患者的住院时间更长。仅一名患者出院时血清肌酐持续升高。有CIN和无CIN的患者在随访中无差异,但CIN 2患者新住院的风险增加。结论结论在中低剂量造影剂PCI后,CIN的发生率有所不同根据使用的定义。与另一个定义相比,这两个定义均未提供其他信息。慢性肾脏疾病和肾功能的基线参数是与CIN 1相关的危险因素。贫血和大量造影剂与CIN 2有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号